This chapter discusses the reasons behind the shortage of generic drugs in the US and the factors that have caused their prices to decline. It explores the role of the FDA in ensuring drug equivalence and the consolidation of companies purchasing these drugs. The chapter also examines the potential consequences of relying on foreign sources for drugs and the challenges of domestic manufacturing.